Search

Geron Corp

Fermé

SecteurSoins de santé

1.55 2.65

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.44

Max

1.54

Chiffres clés

By Trading Economics

Revenu

-13M

-17M

Ventes

5.6M

57M

BPA

-0.02

Marge bénéficiaire

-29.019

Employés

258

EBITDA

-16M

-12M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+184.87% upside

Dividendes

By Acuity

Prochains Résultats

4 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

162M

983M

Ouverture précédente

-1.1

Clôture précédente

1.55

Sentiment de l'Actualité

By Acuity

75%

25%

314 / 340 Classement par Healthcare

Geron Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 août 2026, 23:46 UTC

Geron Corp shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

21 août 2026, 19:46 UTC

Geron Corp shares are lower today, reflecting broader market trends, despite remaining above the 20-day moving average and near the upper end of the one-month range.

20 août 2026, 23:06 UTC

Geron Corp shares are lower in after-market hours, showing notable volatility while remaining above their 20-day moving average and near the month's upper range.

19 août 2026, 19:26 UTC

Geron Corp shares are higher today, continuing a three-day upward trend. The stock remains above its 20-day moving average, indicating strong market positioning.

18 août 2026, 21:03 UTC

News

Geron Corporation's shares are lower in after-market trading following the grant of stock options to new employees at an exercise price of $1.53.

17 août 2026, 23:56 UTC

Geron Corp shares are higher in after-market trading, reflecting notable strength. The stock is significantly above its 20-day moving average.

14 août 2026, 20:02 UTC

Macro Event

Geron Corp shares are lower today amid broader market declines and disappointing U.S. retail sales data, reflecting negative investor sentiment.

13 août 2026, 23:36 UTC

Shares of Geron Corp are trading higher in after-market hours, reflecting a strong performance backdrop despite no specific news identified.

12 août 2026, 23:36 UTC

Geron Corp shares are higher in after-market trading, reflecting an upward move since Wednesday's close. The stock remains above its 20-day moving average.

11 août 2026, 22:52 UTC

Geron Corp shares are lower in after-market trading with no specific news identified. Broader market sentiment was pressured by rising crude oil prices.

10 août 2026, 23:06 UTC

Geron Corp shares are higher in after-market hours, reflecting a gain despite mixed market sentiment and geopolitical tensions affecting global energy markets.

7 août 2026, 20:03 UTC

Geron Corp shares are sharply lower during Friday's trading session, reflecting a broader market decline with no specific news identified to explain the movement.

6 août 2026, 23:06 UTC

Geron Corp shares traded roughly flat in after-market hours, remaining unchanged since Thursday's close amid a strong recent performance backdrop.

5 août 2026, 23:31 UTC

Geron Corp shares are lower in after-market hours, continuing a decline that began during regular trading, with no specific news identified.

4 août 2026, 23:36 UTC

Geron Corp shares are lower in after-market trading, nearing the bottom of their one-month range and below the 20-day moving average.

3 août 2026, 23:06 UTC

Geron Corp shares are lower in after-market hours, continuing a steady decline since Monday's close and remaining below the 20-day moving average.

31 juil. 2026, 20:02 UTC

Geron Corp shares are lower as the Biotechnology sub-sector declines. The stock pulled back from an earlier session high, finishing below its 20-day moving average.

30 juil. 2026, 20:56 UTC

Geron Corp shares are higher in after-market hours, influenced by positive corporate earnings amid broader market uncertainty following the Federal Reserve's interest rate decision.

29 juil. 2026, 19:32 UTC

Macro Event

Geron Corp shares are lower as market volatility rises following the Federal Reserve's interest rate decision amid ongoing economic growth and inflation concerns.

28 juil. 2026, 18:51 UTC

Shares of Geron Corp are lower today amid broader market volatility and uncertainty regarding Federal Reserve decisions. The stock declined since Monday's close.

27 juil. 2026, 23:16 UTC

Geron Corp shares are lower in after-market trading, despite earlier gains, with no specific company news driving the decline.

24 juil. 2026, 19:46 UTC

Geron Corp shares are lower in Friday's session amid broader market volatility and uncertainty from fluctuating oil prices and new U.S. tariffs.

23 juil. 2026, 10:11 UTC

Shares of Geron Corp are higher in pre-market hours, trading above their 20-day moving average. No specific company news was identified.

22 juil. 2026, 18:51 UTC

Geron Corp shares are lower today amid broader market trends, as crude oil prices surge due to geopolitical tensions.

21 juil. 2026, 23:41 UTC

Geron Corp shares are lower in after-market trading, declining to their lowest point since Tuesday's close. No specific news was identified to explain the drop.

20 juil. 2026, 23:56 UTC

Geron Corp shares are lower in after-market hours, continuing a decline since Monday's close amid broader market uncertainties and a drop in the leading economic index.

Comparaison

Variation de prix

Geron Corp prévision

Objectif de Prix

By TipRanks

184.87% hausse

Prévisions sur 12 Mois

Moyen 4.33 USD  184.87%

Haut 6 USD

Bas 3 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

4 ratings

3

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

314 / 340Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
help-icon Live chat